These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9879464)

  • 21. Combined treatment of Nimotuzumab and rapamycin is effective against temozolomide-resistant human gliomas regardless of the EGFR mutation status.
    Chong DQ; Toh XY; Ho IA; Sia KC; Newman JP; Yulyana Y; Ng WH; Lai SH; Ho MM; Dinesh N; Tham CK; Lam PY
    BMC Cancer; 2015 Apr; 15():255. PubMed ID: 25886314
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adenovirus-mediated overexpression of dominant negative epidermal growth factor receptor-CD533 as a gene therapeutic approach radiosensitizes human carcinoma and malignant glioma cells.
    Lammering G; Lin PS; Contessa JN; Hampton JL; Valerie K; Schmidt-Ullrich RK
    Int J Radiat Oncol Biol Phys; 2001 Nov; 51(3):775-84. PubMed ID: 11697324
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiglioma effects of N6-isopentenyladenosine, an endogenous isoprenoid end product, through the downregulation of epidermal growth factor receptor.
    Ciaglia E; Abate M; Laezza C; Pisanti S; Vitale M; Seneca V; Torelli G; Franceschelli S; Catapano G; Gazzerro P; Bifulco M
    Int J Cancer; 2017 Feb; 140(4):959-972. PubMed ID: 27813087
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long Non-Coding RNA HOXA-AS2 Regulates Malignant Glioma Behaviors and Vasculogenic Mimicry Formation via the MiR-373/EGFR Axis.
    Gao Y; Yu H; Liu Y; Liu X; Zheng J; Ma J; Gong W; Chen J; Zhao L; Tian Y; Xue Y
    Cell Physiol Biochem; 2018; 45(1):131-147. PubMed ID: 29310118
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combination therapy with Gamma Knife radiosurgery and antisense EGFR for malignant glioma in vitro and orthotopic xenografts.
    Li Y; Jia Q; Zhang J; Han L; Xu D; Zhang A; Zhang Y; Zhang Z; Pu P; Kang C
    Oncol Rep; 2010 Jun; 23(6):1585-91. PubMed ID: 20428813
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oncogenic dependence of glioma cells on kish/TMEM167A regulation of vesicular trafficking.
    Portela M; Segura-Collar B; Argudo I; Sáiz A; Gargini R; Sánchez-Gómez P; Casas-Tintó S
    Glia; 2019 Feb; 67(2):404-417. PubMed ID: 30506943
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deletion-mutant epidermal growth factor receptor in human gliomas: effects of type II mutation on receptor function.
    Humphrey PA; Gangarosa LM; Wong AJ; Archer GE; Lund-Johansen M; Bjerkvig R; Laerum OD; Friedman HS; Bigner DD
    Biochem Biophys Res Commun; 1991 Aug; 178(3):1413-20. PubMed ID: 1678600
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DSE promotes aggressive glioma cell phenotypes by enhancing HB-EGF/ErbB signaling.
    Liao WC; Liao CK; Tsai YH; Tseng TJ; Chuang LC; Lan CT; Chang HM; Liu CH
    PLoS One; 2018; 13(6):e0198364. PubMed ID: 29864158
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RIZ1: a potential tumor suppressor in glioma.
    Zhang C; Zhu Q; He H; Jiang L; Qiang Q; Hu L; Hu G; Jiang Y; Ding X; Lu Y
    BMC Cancer; 2015 Dec; 15():990. PubMed ID: 26690953
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel monoclonal antibody specific for the de2-7 epidermal growth factor receptor (EGFR) that also recognizes the EGFR expressed in cells containing amplification of the EGFR gene.
    Johns TG; Stockert E; Ritter G; Jungbluth AA; Huang HJ; Cavenee WK; Smyth FE; Hall CM; Watson N; Nice EC; Gullick WJ; Old LJ; Burgess AW; Scott AM
    Int J Cancer; 2002 Mar; 98(3):398-408. PubMed ID: 11920591
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of proliferation and apoptosis in brain gliomas: prognostic and clinical value.
    Heesters MA; Koudstaal J; Go KG; Molenaar WM
    J Neurooncol; 1999; 44(3):255-66. PubMed ID: 10720205
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular targeting of the epidermal growth factor receptor for neutron capture therapy of gliomas.
    Barth RF; Yang W; Adams DM; Rotaru JH; Shukla S; Sekido M; Tjarks W; Fenstermaker RA; Ciesielski M; Nawrocky MM; Coderre JA
    Cancer Res; 2002 Jun; 62(11):3159-66. PubMed ID: 12036929
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Growth factor receptors and their ligands.
    Eppenberger U; Mueller H
    J Neurooncol; 1994; 22(3):249-54. PubMed ID: 7760103
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cells with intense EGFR staining and a high nuclear to cytoplasmic ratio are specific for infiltrative glioma: a useful marker in neuropathological practice.
    Burel-Vandenbos F; Turchi L; Benchetrit M; Fontas E; Pedeutour Z; Rigau V; Almairac F; Ambrosetti D; Michiels JF; Virolle T
    Neuro Oncol; 2013 Oct; 15(10):1278-88. PubMed ID: 23935154
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Growth factor receptor expression varies among high-grade gliomas and normal brain: epidermal growth factor receptor has excellent properties for interstitial fusion protein therapy.
    Liu TF; Tatter SB; Willingham MC; Yang M; Hu JJ; Frankel AE
    Mol Cancer Ther; 2003 Aug; 2(8):783-7. PubMed ID: 12939468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interaction of transforming growth factor-beta (TGF-beta) and epidermal growth factor (EGF) in human glioma cells.
    Held-Feindt J; Lütjohann B; Ungefroren H; Mehdorn HM; Mentlein R
    J Neurooncol; 2003 Jun; 63(2):117-27. PubMed ID: 12825816
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibitory effect of antisense epidermal growth factor receptor RNA on the proliferation of rat C6 glioma cells in vitro and in vivo.
    Pu P; Liu X; Liu A; Cui J; Zhang Y
    J Neurosurg; 2000 Jan; 92(1):132-9. PubMed ID: 10616092
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The correlation between the expression of ADAM17, EGFR and Ki-67 in malignant gliomas.
    Sun J; Li DM; Huang J; Liu J; Sun B; Fu DL; Mao GS
    Eur Rev Med Pharmacol Sci; 2017 Oct; 21(20):4595-4599. PubMed ID: 29131255
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Melanoma differentiation associated gene-7, mda-7/IL-24, selectively induces growth suppression, apoptosis and radiosensitization in malignant gliomas in a p53-independent manner.
    Su ZZ; Lebedeva IV; Sarkar D; Gopalkrishnan RV; Sauane M; Sigmon C; Yacoub A; Valerie K; Dent P; Fisher PB
    Oncogene; 2003 Feb; 22(8):1164-80. PubMed ID: 12606943
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Growth effects of epidermal growth factor (EGF) and a monoclonal antibody against the EGF receptor on four glioma cell lines.
    Werner MH; Humphrey PA; Bigner DD; Bigner SH
    Acta Neuropathol; 1988; 77(2):196-201. PubMed ID: 3265834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.